Gen-Probe Licenses Technology from AdnaGen That May Increase Accuracy of Molecular Diagnostic Tests for Cancer
Innovative 'Immunocapture' Technology Combined with NAT Also May Help Determine Aggressiveness of Malignancies and Aid in Patient Monitoring
20-Jan-2005 -
Gen-Probe has licensed technology from AdnaGen that may help increase the accuracy of molecular
diagnostic tests to detect prostate and other cancers, help determine the
aggressiveness of these malignancies, and monitor responses to therapy.
AdnaGen's proprietary technology enables detection of ...
acids
cancer metastasis
circulating tumor cells
+4